Roche Pharma launches multiple sclerosis treatment drug in India
The company has introduced Ocrevus (Ocrelizumab) which is the first and only approved disease modifying therapy for both Relapsing Remitting Multiple Sclerosis (RRMS) and Primary Progressive Multiple Sclerosis (PPMS). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 27, 2024 Category: Pharmaceuticals Source Type: news

Miltenyi Biotec launches India operations, to open Centre in Hyderabad
German biomedical discovery provider Miltenyi Biotec is launching operations in India, opening its first office and setting up a Centre of Excellence. The CoE will offer training in cell and gene therapy and contribute to the vibrant life sciences ecosystem by supporting local development and manufacturing in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 27, 2024 Category: Pharmaceuticals Source Type: news

Cancer drugmaker Bristol Myers to build its largest R&D facility outside US in India by 2025
The $100-million facility, inaugurated by Boerner on Monday, is expected to employ over 1,500 employees and will be used to enhance its drug development through the use of digital technologies and artificial intelligence, he said in his keynote speech at the BioAsia conference. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 27, 2024 Category: Pharmaceuticals Source Type: news

Takeda, Biological E enter manufacturing pact to produce 50 million doses of Dengue vaccine
Japanese drug giant Takeda has partnered with Indian vaccine maker Biological E (BE) to manufacture its Dengue vaccine. BE will increase its manufacturing capacity to up to 50 million doses a year, supporting Takeda's goal to produce 100 million doses annually by 2030. The collaboration leverages Takeda's existing facility in Germany and its partnership with IDT Biologika GmbH. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 27, 2024 Category: Pharmaceuticals Source Type: news

Pharma companies producing drugs, supplements in same unit under lens
The government, DCGI, and state authorities are cracking down on pharma units manufacturing nutraceuticals, health supplements, and drugs in the same facility. The industry is worried about the impact on exports, domestic market, spurious drugs, and foreign exchange. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 26, 2024 Category: Pharmaceuticals Source Type: news

Bristol Myers Squibb opens innovation hub in Hyderabad
Bristol Myers Squibb (BMS) has opened an innovation hub in Hyderabad, India, to expand its global drug development, information technology, and digital capabilities. The facility, expected to house over 1,500 employees, represents an investment of over $100 million. BMS aims to accelerate drug development, enhance digital capabilities, and diversify its global workforce by tapping into local talent in Hyderabad. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 26, 2024 Category: Pharmaceuticals Source Type: news

Mankind counters objections raised by chemists body on supplement ad
Mankind Pharma, ranked as the fourth largest pharmaceutical company in the country, has responded to objections raised by a retail chemists' association regarding its advertisement for the vitamin supplement, HealthOK. The All India Organisation of Chemists and Druggists (AIOCD) had requested the withdrawal of the advertisement, alleging that it implies non-vegetarians are healthier due to its portrayal of actor Ranveer Singh. In a letter dated February 13th, Mankind Pharma addressed the concerns raised by the AIOCD. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 25, 2024 Category: Pharmaceuticals Source Type: news

Biocon gets over Rs 3 crore penalty over GST related issues
Biocon said it is "in the process of taking appropriate actions, including but not limited to, filing of the necessary appeal with the appellate authority in this regard". There is no material impact on the financials, operations or other activities of the company, the filing said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 23, 2024 Category: Pharmaceuticals Source Type: news

Several small pharma units told to halt operations over quality
The Central Drugs Standard Control Organisation (CDSCO) has been conducting risk-based inspections of drug manufacturing units as part of a nationwide crackdown on spurious and substandard drugs. Several units in Baddi, Himachal Pradesh, and Punjab have been inspected, with show-cause notices issued and production stopped at some. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 22, 2024 Category: Pharmaceuticals Source Type: news

Northeastern India’s first API/Bulk Drug Plant inaugurated in Guwahati
Chemex Global's pharmaceutical API manufacturing facility in Guwahati, first of its kind in the region, positions Assam as the next big pharma hub in India. It aims to expand trade routes with Gujarat, Hyderabad, Sikkim, and Southeast Asia. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 22, 2024 Category: Pharmaceuticals Source Type: news

India’s API industry faces high leadership talent churn: Report
Talent churn in manufacturing leadership is currently at about 40% and the trend is expected to continue, given the demand supply gap with the API industry attracting robust investments, the executive search firm said in a report on Thursday. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 22, 2024 Category: Pharmaceuticals Source Type: news

India pharma companies develop versions of Wegovy to get in on weight-loss windfall
Indian drugmakers are developing their versions of Novo Nordisk's weight-loss treatment, Wegovy, aiming to capitalize on the growing weight-loss market, expected to reach $100 billion a year by the end of the decade. Companies like Sun Pharma, Cipla, Dr Reddy's, and Lupin are working on Wegovy alternatives as Novo Nordisk struggles to meet global demand. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 22, 2024 Category: Pharmaceuticals Source Type: news

Medplus decides against fund raising, puts diagnostic expansion on hold
Medplus, a pharmacy retail chain based in Hyderabad, has decided to abandon its proposed Rs 1200 crore fundraising plan and has halted the expansion of its diagnostic business. The company will focus on expanding its pharmacy business using internal accruals and working capital loans. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 21, 2024 Category: Pharmaceuticals Source Type: news

Global companies account for 60% of Indian vaccine sales by value
India's vaccine market is steadily recovering after the impact from Covid-19 and multinationals are back to slowly gaining traction, suggest data from research firm PharmaTrac. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 20, 2024 Category: Pharmaceuticals Source Type: news

'No occasion' to approach regulators: Religare
The firm said in its communication to the Securities and Exchange Board of India (Sebi), Reserve Bank of India, and the Insurance Regulatory and Development Authority of India (IRDAI), that it would proceed with seeking their approval after the regulators give their decisions on the alleged violations by the Burmans. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 20, 2024 Category: Pharmaceuticals Source Type: news